| Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns BMN Kagina, B Abel, TJ Scriba, EJ Hughes, A Keyser, A Soares, ... American journal of respiratory and critical care medicine 182 (8), 1073-1079, 2010 | 506 | 2010 |
| Four-gene pan-African blood signature predicts progression to tuberculosis S Suliman, EG Thompson, J Sutherland, J Weiner 3rd, MOC Ota, ... American journal of respiratory and critical care medicine 197 (9), 1198-1208, 2018 | 273 | 2018 |
| First-in-human trial of the post-exposure tuberculosis vaccine H56: IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults AKK Luabeya, BMN Kagina, MD Tameris, H Geldenhuys, ST Hoff, Z Shi, ... Vaccine 33 (33), 4130-4140, 2015 | 219 | 2015 |
| Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response BMN Kagina, B Abel, M Bowmaker, TJ Scriba, S Gelderbloem, E Smit, ... Vaccine 27 (40), 5488-5495, 2009 | 149 | 2009 |
| Metabolite changes in blood predict the onset of tuberculosis J Weiner 3rd, J Maertzdorf, JS Sutherland, FJ Duffy, E Thompson, ... Nature communications 9 (1), 5208, 2018 | 145 | 2018 |
| Improving vaccination uptake among adolescents LH Abdullahi, BM Kagina, VN Ndze, GD Hussey, CS Wiysonge Cochrane Database of Systematic Reviews, 2020 | 133 | 2020 |
| Discovery and validation of a prognostic proteomic signature for tuberculosis progression: a prospective cohort study A Penn-Nicholson, T Hraha, EG Thompson, D Sterling, SK Mbandi, ... PLoS medicine 16 (4), e1002781, 2019 | 93 | 2019 |
| Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity JS Sutherland, AG Loxton, MC Haks, D Kassa, L Ambrose, JS Lee, L Ran, ... Clinical microbiology and infection 20 (4), O230-O238, 2014 | 88 | 2014 |
| Higher human CD4 T cell response to novel Mycobacterium tuberculosis latency associated antigens Rv2660 and Rv2659 in latent infection compared with tuberculosis disease L Govender, B Abel, EJ Hughes, TJ Scriba, BMN Kagina, M De Kock, ... Vaccine 29 (1), 51-57, 2010 | 85 | 2010 |
| Safety and Immunogenicity of H1/IC31®, an Adjuvanted TB Subunit Vaccine, in HIV-Infected Adults with CD4+ Lymphocyte Counts Greater than 350 cells/mm3: A … K Reither, L Katsoulis, T Beattie, N Gardiner, N Lenz, K Said, E Mfinanga, ... PLoS One 9 (12), e114602, 2014 | 82 | 2014 |
| Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry BM Kagina, N Mansoor, EP Kpamegan, A Penn-Nicholson, E Nemes, ... Journal of immunological methods 417, 22-33, 2015 | 72 | 2015 |
| Analysis of Host Responses to Mycobacterium tuberculosis Antigens in a Multi-Site Study of Subjects with Different TB and HIV Infection States in Sub-Saharan Africa JS Sutherland, MK Lalor, GF Black, LR Ambrose, AG Loxton, NN Chegou, ... PloS one 8 (9), e74080, 2013 | 69 | 2013 |
| The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses BMN Kagina, MD Tameris, H Geldenhuys, M Hatherill, B Abel, GD Hussey, ... Vaccine 32 (45), 5908-5917, 2014 | 59 | 2014 |
| Performance of diagnostic and predictive host blood transcriptomic signatures for Tuberculosis disease: A systematic review and meta-analysis H Mulenga, CZ Zauchenberger, EW Bunyasi, SK Mbandi, ... PLoS One 15 (8), e0237574, 2020 | 56 | 2020 |
| Human newborn bacille Calmette–Guérin vaccination and risk of tuberculosis disease: a case-control study HA Fletcher, A Filali-Mouhim, E Nemes, A Hawkridge, A Keyser, S Njikan, ... BMC medicine 14, 1-13, 2016 | 56 | 2016 |
| A systematic review of the epidemiology of hepatitis A in Africa J Patterson, L Abdullahi, GD Hussey, R Muloiwa, BM Kagina BMC infectious diseases 19, 1-15, 2019 | 53 | 2019 |
| T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection M Musvosvi, H Huang, C Wang, Q Xia, V Rozot, A Krishnan, P Acs, ... Nature Medicine 29 (1), 258-269, 2023 | 51 | 2023 |
| H1: IC31 vaccination is safe and induces long-lived TNF-α+ IL-2+ CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial H Mearns, HD Geldenhuys, BM Kagina, M Musvosvi, F Little, F Ratangee, ... Vaccine 35 (1), 132-141, 2017 | 51 | 2017 |
| Health systems constraints and facilitators of human papillomavirus immunization programmes in sub-Saharan Africa: a systematic review E Amponsah-Dacosta, BM Kagina, J Olivier Health policy and planning 35 (6), 701-717, 2020 | 49 | 2020 |
| Immunometabolic signatures predict risk of progression to active tuberculosis and disease outcome FJ Duffy, J Weiner III, S Hansen, DL Tabb, S Suliman, E Thompson, ... Frontiers in immunology 10, 527, 2019 | 49 | 2019 |
Willem HanekomAfrica Health Research InstituteEmail verificata su ahri.org
